MiR-211 is confirmed to inhibit cells proliferation in thyroid cancer 26 and cervical cancer 38 by regulating secreted protein acidic and rich in cysteine (SPARC), which is an extracellular matrix glycoprotein. The gene discussed is SPARC; the disease is thyroid gland carcinoma.